2. DEHP

DEHP  (Synonyms: Bis(2-ethylhexyl) phthalate; Ergoplast FDO; ESBO-D 82)

Cat. No.: HY-B1945 Purity: 99.95%
COA Handling Instructions

Molarity Calculator

DEHP (Bis(2-ethylhexyl) phthalate) is a widely used plasticizer, which has orally active. DEHP can produce a wide spectrum of toxic effects on organisms including neurotoxicity, liver toxicity, immunotoxicity, and reproductive toxicity.

For research use only. We do not sell to patients.

DEHP Chemical Structure

DEHP Chemical Structure

CAS No. : 117-81-7

Size Price Stock Quantity
Liquid + Solvent
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 73 In-stock
Solution
10 mM * 1 mL in DMSO USD 73 In-stock
Liquid
100 mg USD 66 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of DEHP:

DEHP Related Antibodies

Top Publications Citing Use of Products

1 Publications Citing Use of MCE DEHP

  • Biological Activity

  • Purity & Documentation

  • Customer Review

Description

DEHP (Bis(2-ethylhexyl) phthalate) is a widely used plasticizer, which has orally active. DEHP can produce a wide spectrum of toxic effects on organisms including neurotoxicity, liver toxicity, immunotoxicity, and reproductive toxicity[1][2].

In Vitro

DEHP (0-160 µM, 48 h) dramatically inhibits cell viability in mouse GC-1 spg cells[1].
DEHP (0-160 µM, 48 h) induces autophagy and apoptosis of mouse GC-1 spg cells via oxidative stress[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

DEHP Related Antibodies

Western Blot Analysis[1]

Cell Line: Mouse GC-1 spg cells
Concentration: 0-160 µM
Incubation Time: 48 h
Result: Decreased Bcl-2 level.
Increased the levels of Bax, cleaved Caspase-3, and cleaved Caspase-8.
Increased the levels of LC3-II, Beclin1, and Atg5, as well as the ratio of LC3-II/LC3-I.
In Vivo

DEHP (0-500 mg/kg, p.o., daily, 8 weeks) impairs fertility of female C3H/N mice[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female C3H/N mice[1]
Dosage: 0-500 mg/kg
Administration: p.o., daily, 8 weeks
Result: Increased the body weight and visceral fat tissue.
Increased the expression of PPARα and PPARγ mRNA at the dose of 500 mg/kg.
Decreased mRNA expression of PPARα transcripts/106 18S molecules at the dose of 500 mg/kg.
Reduced the level of adiponectin mRNA.
Increased the mRNA concentration of FABP4 at the dose of 0.05 mg/kg.
Molecular Weight

390.56

Formula

C24H38O4
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

O=C(C1=CC=CC=C1C(OCC(CC)CCCC)=O)OCC(CC)CCCC
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 150 mg/mL (384.06 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

0.1 M NaOH : 6.67 mg/mL (17.08 mM; ultrasonic and warming and adjust pH to 10 with 0.1 M NaOH and heat to 60°C)

H2O : < 0.1 mg/mL (insoluble)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.5604 mL 12.8021 mL 25.6043 mL
5 mM 0.5121 mL 2.5604 mL 5.1209 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 1.25 mg/mL (3.20 mM); Clear solution

    This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% Corn Oil

    Solubility: ≥ 1.25 mg/mL (3.20 mM); Clear solution

    This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
% 
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.95%

COA (249 KB) LCMS (98 KB)

Handling Instructions (2659 KB)

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
0.1 M NaOH / DMSO 1 mM 2.5604 mL 12.8021 mL 25.6043 mL 64.0107 mL
5 mM 0.5121 mL 2.5604 mL 5.1209 mL 12.8021 mL
10 mM 0.2560 mL 1.2802 mL 2.5604 mL 6.4011 mL
15 mM 0.1707 mL 0.8535 mL 1.7070 mL 4.2674 mL
DMSO 20 mM 0.1280 mL 0.6401 mL 1.2802 mL 3.2005 mL
25 mM 0.1024 mL 0.5121 mL 1.0242 mL 2.5604 mL
30 mM 0.0853 mL 0.4267 mL 0.8535 mL 2.1337 mL
40 mM 0.0640 mL 0.3201 mL 0.6401 mL 1.6003 mL
50 mM 0.0512 mL 0.2560 mL 0.5121 mL 1.2802 mL
60 mM 0.0427 mL 0.2134 mL 0.4267 mL 1.0668 mL
80 mM 0.0320 mL 0.1600 mL 0.3201 mL 0.8001 mL
100 mM 0.0256 mL 0.1280 mL 0.2560 mL 0.6401 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

DEHP117-81-7Bis(2-ethylhexyl) phthalate Ergoplast FDO ESBO-D 82Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
DEHP
Cat. No.:
HY-B1945
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.